Reproductive Endocrine Disorders in Women with Primary Generalized Epilepsy

Epilepsia

Volumn 29, Issue 5, 1988, Pages 612-619

  Bilo, Leonilda ^a   Meo, Roberta ^a   Nappi, Carmine ^a   Annunziato, Lucio ^a   Striano, Salvatore ^a   Colao, Anna Maria ^a   Merola, Bartolomeo ^a   Buscaino, Giuseppe Andrea ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Anticonvulsants; Follicle stimulating hormone; Hypothalamus; Ovarian disorders; Polycystic ovary syndrome; Primary generalized epilepsy; Prolactin

Indexed keywords

FOLLITROPIN; GONADORELIN; PHENOBARBITAL; PROLACTIN; VALPROIC ACID;

ADULT; CLINICAL ARTICLE; ENDOCRINE DISEASE; EPILEPSY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; OVARY CYST; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ENDOCRINE DISEASES; EPILEPSY; FEMALE; HUMAN; LUTEINIZING HORMONE; MENSTRUATION DISTURBANCES; PITUITARY HORMONE-RELEASING HORMONES;

EID: 0023755272     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1988.tb03770.x     Document Type: Article

References (82)

1. Serum prolactin and Cortisol concentrations after grand mal seizures
2. The hormonal responses to generalized tonic‐clonic seizures
3. The effect on plasma prolactin levels of interictal epileptiform EEG activity
4. Epilepsy in women. Oestrogen and progesterone plasma levels
5. Testosterone‐estradiol‐binding globulin, unbound and total estradiol and testosterone, and total progesterone during the menstrual cycle in women with epilepsy taking antiepileptic drugs
6. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy
7. Effect of anticonvulsants on plasma testosterone and sex hormone binding globulin levels
8. Serum prolactin evaluation after “minor” generalised seizures monitored by EEG
9. Livelli plasmatici di prolattina in soggetti trattati con fenobarbital
10. Prolactin secretion in epileptic subjects treated with phenobarbital: sex differences and circadian periodicity
11. Evaluation of the obese patient
12. La predisposizione alľ' epilessia. Problemi di ieri, problemi di oggi
13. Plasma prolactin and Cortisol concentrations in epileptic patients during the night
14. Plasma prolactin concentrations following epileptic and pseudoseizures
15. Hypothalamic pituitary function testing on children receiving carbamazepine or sodium valproate
16. Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome
17. Reduction of free testosterone by anti‐epileptic drugs
18. Prolactin and gonadotropin changes following generalised and partial seizures
19. Pituitary responsiveness to gonadotrophin‐releasing and thyrotrophin‐releasing hormones in epileptic patients receiving carbamazepine or phe‐nytoin
20. A presumptive role for gamma‐aminobutyric acid in the regulation of gonadotropin secretion in man
21. Sexual behaviour in a centre for epilepsy
22. The hypothalamic control of menstrual cycle and the role of endogenous opioid peptides
23. Effects of long‐term antiepileptic therapy on the hypothalamic‐pituitary axis in man
24. Pituitary and adrenal function in epileptic patients
25. Le controle gabaergique de la fonction gonadotrope hy‐pophysaire, et de la prolactine
26. Generalized epilepsy with spike‐and‐wave discharges: a reinterpretation of its electrographic and clinical manifestations
27. Electrophysiology of generalized epilepsy
28. Effects of changes in cortical excitability upon the epileptic bursts in generalized penicillin epilepsy of the cat
29. Prediction of intrauterine growth retardation by determination of total intrauterine volume
30. The effect of intermittent progesterone therapy on the frequency of complex partial seizures among women with menstrual disorders
31. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin
32. Polycystic ovaries and polycystic ovary syndrome
33. Plasma amino acids in epilepsy
34. Neuroendocrine effects of carbamazepine in patients with affective illness
35. The effects of antiepileptic drugs on estrogen‐induced electrographic spike‐wave discharge
36. The neuroendocrine control of the menstrual cycle
37. Catamenial epilepsy
38. Re‐evaluation of estrogen‐induced cortical and thalamic paroxysmal EEG activity in the cat
39. Prolactin changes after seizures classified by EEG monitoring
40. The pathophysiology of hypothalamic ovarian failure. Diagnostic and therapeutical considerations
41. Induction of ovulation with chronic intermittent (pulsatile) administration of GnRH in women with hypothalamic amenorrhoea
42. Hypothalamic ovarian failure
43. The role of estrogens in catamenial exacerbation of epilepsy
44. Hormonal effects of anticonvulsant drugs
45. The effect of anti‐convulsant drugs (AED) on hormonal responses in normal volunteers
46. The influence of phenytoin and carbamazepine on endocrine function: preliminary results
47. Influence of valproic acid on the gonadotropin‐releasing hormone test in puberty
48. The effect of phenobar‐bital on serum hormone levels and their diurnal variations in pregnancy
49. An experimental model of some varieties of petit mal epilepsy: electrical‐behavioral correlations of acute bilateral epileptogenic foci in cerebral cortex
50. Pituitary responsiveness to gonadotrophin‐releasing and thy‐rotrophin‐releasing hormones in children receiving phenobar‐bitone
51. Effect of long‐term treatment with sodium valproate on gonadotrophin and prolactin secretion in paediatric patients
52. GABA and gonadotropin secretion: evidence from in vitro studies on regulation of LHRH secretion
53. Treatment of seizures with medroxyprogesterone acetate: Preliminary report
54. Epilepsy, sex hormones and antiepileptic drugs
55. The effects of the GABAergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects
56. Effects of the GABAergic drug, sodium valproate, on the prolactin release evoked by pharmacological stimuli in normal women
57. GABAergic control of anterior pituitary function in humans
58. Involvement of endogenous GABAergic system in the modulation of gonadotropin secretion in normal cycling women
59. Effetti del sodio valproato sulľ'increzione di prolattina
60. Petit mal epilepsy: a review and integration of recent information
61. Nocturnal plasma prolactin and Cortisol levels in epileptics with complex partial seizures and primary generalized seizures
62. Polycystic ovarian disease: a pathogenetic problem
63. Petit mal epilepsy: too little or too much GABA
64. Epidemiology of secondary amenorrhea. Incidence and prevalence rates
65. Transient abolition of generalized photosensitive epileptic discharge in humans by apomorphine, a dopamine‐receptor agonist
66. Dopaminergic mechanism in generalized photosensitive epilepsy
67. Increased luteinizing hormone sensitivity to dopamine inhibition in polycystic ovary syndrome
68. New concepts in the regulation of hypothalamic gonadotropin releasing hormone (GnRH) secretion
69. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome
70. Investigation of sex hormones in male epileptic patients
71. Effects of a single oral dose of phenobarbital on prolactin, growth hormone and luteinizing hormone in normal women
72. Endocrine function changes in young males during long‐term antiepileptic therapy with phe‐nobarbitone and carbamazepine
73. Epilessia gen‐eralizzata primaria grande male e ciclo mestruale
74. The role of hormones in the development of seizures
75. Sex hormones, sexual activity and plasma anticonvulsant levels in male epileptics
76. Serum prolactin in epilepsy and hysteria
77. Plasma aminoacids in 3 per second spike‐wave epilepsy
78. Feline generalized penicillin epilepsy. Changes of glutamic acid and taurine parallel the progressive increase in excitability of the cortex
79. The gonad‐brain relationship: effects of female sex hormones on electroshock convulsions in the rat
80. The polycystic ovary syndrome